-
Electronic (PDF)
-
Site License
-
Enterprisewide
Emergency Contraception in France
Euromonitor International, April 2012, Pages: 27
Current value sales of emergency contraception grew by 9% in 2011. This growth was relatively similar to but slightly lower than the CAGR observed during the review period. Even if there are some reimbursed RX emergency contraception medicines available in the marketplace, to get them women need to visit a doctor beforehand this is not necessarily possible in urgent cases of contraception failure or unprotected sex. As a result, French women continue to purchase OTC emergency contraception...
Euromonitor International's Emergency Contraception in France report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2007-2011, allowing you to identify the sectors driving growth. Forecasts to 2016 illustrate how the market is set to change.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
- Get a detailed picture of the Emergency Contraception market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.
EMERGENCY CONTRACEPTION IN FRANCE
Euromonitor International
April 2012
LIST OF CONTENTS AND TABLES
Headlines
Trends
Switches
Competitive Landscape
Prospects
Category Data
Table 1 Sales of Emergency Contraception: Value 2006-2011
Table 2 Sales of Emergency Contraception: % Value Growth 2006-2011
Table 3 Emergency Contraception Company Shares by Value 2007-2011
Table 4 Emergency Contraception Brand Shares by Value 2008-2011
Table 5 Forecast Sales of Emergency Contraception: Value 2011-2016
Table 6 Forecast Sales of Emergency Contraception: % Value Growth 2011-2016
Executive Summary
Consumer Health Registers Low But Positive Value Growth in 2011
Ageing Population and Concentration in Urban Areas, Key Growth Drivers
Direct Selling and Herbal Products Behind Best-performing Operators
Pharmacies Still the Most Common Retailer for Consumer Health Products
Modest Growth Expected Over the Forecast Period
Key Trends and Developments
Hectic Lifestyles Behind Good Performances of Some Categories of OTC Drugs
Ageing Population A Major Driver for Consumer Health
Weight Management, the Most Affected by the Weak Economic Context
Transfer of Rx Drugs To OTC Market Continues To Boost Growth Potential
French Consumers Increasingly Receptive To Oral Nrt Smoking Cessation Aids
Market Indicators
Table 7 Consumer Expenditure on Health Goods and Medical Services 2006-2011
Table 8 Life Expectancy at Birth 2006-2011
Market Data
Table 9 Sales of Consumer Health by Category: Value 2006-2011
Table 10 Sales of Consumer Health by Category: % Value Growth 2006-2011
Table 11 Consumer Health Company Shares 2007-2011
Table 12 Consumer Health Brand Shares 2008-2011
Table 13 Penetration of Private Label by Category 2006-2011
Table 14 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
Table 15 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011
Table 16 Forecast Sales of Consumer Health by Category: Value 2011-2016
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016
Appendix
OTC Registration and Classification
Advertising
Packaging and Labelling
Distribution
Vitamins and Dietary Supplements Registration and Classification
EU Legislation
Self-medication/self-care and Preventive Medicine
Generics
Switches
Summary 1 OTC - Switches 2009-2011
Definitions
Sources
Summary 2 Research Sources
Customers who bought this item also bought
All rights reserved. © Copyright 2013 Research and Markets WWW4
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
